Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D000090984
http://purl.bioontology.org/ontology/MESH/D000090984
|
|---|---|
| Preferred Name | Ad26COVS1 |
| Definitions |
A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.
|
| Synonyms |
Ad26.COV2.S
JNJ78436735
JNJ 78436735
Johnson & Johnson Covid 19 Vaccine
Johnson & Johnson Covid-19 Vaccine
COVID-19 Vaccine Johnson & Johnson
COVID 19 Vaccine Johnson & Johnson
JNJ-78436735
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein. |
|---|---|
| altLabel |
Ad26.COV2.S
JNJ78436735
JNJ 78436735
Johnson & Johnson Covid 19 Vaccine
Johnson & Johnson Covid-19 Vaccine
COVID-19 Vaccine Johnson & Johnson
COVID 19 Vaccine Johnson & Johnson
JNJ-78436735
See more
See less
|
| prefLabel | Ad26COVS1
|
| Machine permutation | 2022; AD26COVS1 was indexed under COVID-19 VACCINES 2021
|
| HN | 2022
|
| type | |
| tui |
T116
T129
T121
|
| TERMUI |
T001095868
T001095866
T001115266
T001105740
T001094954
T001094953
See more
See less
|
| TH |
NLM (2022)
NLM (2021)
|
| MMR | 20220101
|
| notation | D000090984
|
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| DX | 20220101
|
| cui |
C5544455
C5416833
C5416855
|
| DC | 1
|
| MN | D20.215.894.899.085.125
|
| AQL | AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR
|
| Inverse of RB |
JT2NS6183B
0
|
| MDA | 20210115
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |